Literature DB >> 15271418

Nuclear factor kappa B--molecular biomedicine: the next generation.

Peter Celec1.   

Abstract

Nuclear factor kappa B (NFkappaB) as a transcription factor plays an important integrating role in the intracellular regulation of immune response, inflammation and cell cycle regulation. Nouvelle insights into the structure and regulation of activation of NFkappaB have brought a detailed picture of the function of this transcription factor. In this review the findings of interactions of NFkappaB with its inhibitors, tumour necrosis factor alpha and glucocorticoids are presented. The results from the latest in vivo studies show the capability of specific NFkappaB inhibitors in the clinical use. This article summarizes the most important facts regarding NFkappaB participation in the pathogenesis of diseases and its potential as a target of pharmacological agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271418     DOI: 10.1016/j.biopha.2003.12.015

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  22 in total

1.  Characteristics of lymphocyte nuclear factor-κB signal transduction kinase expression in aging process and regulatory effect of epimedium flavonoids.

Authors:  Xiao-yu Liu; Qi Wang; Shi-jin Xia; Jian-hua Huang; Zi-yin Shen; Hao Xu
Journal:  Chin J Integr Med       Date:  2011-09-11       Impact factor: 1.978

2.  Protective effects of isorhamnetin on apoptosis and inflammation in TNF-α-induced HUVECs injury.

Authors:  Tie-Long Chen; Guang-Li Zhu; Jian-An Wang; Guo-Dong Zhang; Hong-Fei Liu; Jin-Ru Chen; Yu Wang; Xiao-Long He
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 3.  The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors.

Authors:  Mario Di Napoli; BethAnn McLaughlin
Journal:  Curr Opin Investig Drugs       Date:  2005-07

4.  Shikonin reduces oedema induced by phorbol ester by interfering with IkappaBalpha degradation thus inhibiting translocation of NF-kappaB to the nucleus.

Authors:  I Andújar; M C Recio; T Bacelli; R M Giner; J L Ríos
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

5.  Toll-like receptor ligand-induced activation of murine DC2.4 cells is attenuated by Panax notoginseng.

Authors:  Ava Rhule; Benjamin Rase; Jerry R Smith; David M Shepherd
Journal:  J Ethnopharmacol       Date:  2007-11-22       Impact factor: 4.360

6.  Inhibition of nitric oxide synthase and farnesyltransferase change the activities of several transcription factors.

Authors:  E Zhuravliova; T Barbakadze; N Narmania; J Ramsden; D Mikeladze
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

7.  Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart.

Authors:  Harjot K Saini; Yan-Jun Xu; Ming Zhang; Peter P Liu; Lorrie A Kirshenbaum; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2005

8.  Proteomic analyses of the effects of drugs of abuse on monocyte-derived mature dendritic cells.

Authors:  Jessica L Reynolds; Supriya D Mahajan; Ravikunar Aalinkeel; B Nair; Donald E Sykes; Stanley A Schwartz
Journal:  Immunol Invest       Date:  2009       Impact factor: 3.657

9.  Adipocyte reporter assays: application for identification of anti-inflammatory and antioxidant properties of mangosteen xanthones.

Authors:  Qiwen Shen; Chureeporn Chitchumroonchokchai; Jaisa L Thomas; Liubov V Gushchina; David Disilvestro; Mark L Failla; Ouliana Ziouzenkova
Journal:  Mol Nutr Food Res       Date:  2013-09-03       Impact factor: 5.914

10.  The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system.

Authors:  Madhavan P Nair; Supriya Mahajan; Jessica L Reynolds; Ravikumar Aalinkeel; Harikrishnan Nair; Stanley A Schwartz; Chithan Kandaswami
Journal:  Clin Vaccine Immunol       Date:  2006-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.